Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
- Status
- COMPLETED
- Phase
- PHASE4
First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE3
Twinrix Pregnancy Registry
- Status
- COMPLETED
- Phase
- N/A
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance
- Status
- COMPLETED
- Phase
- NA
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting
- Status
- COMPLETED
- Phase
- N/A
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of GSK2982772 in Japanese Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Two Toothpastes on Bacteria in Saliva
- Status
- COMPLETED
- Phase
- NA
Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
- Status
- COMPLETED
- Phase
- PHASE2
Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis
- Status
- COMPLETED
- Phase
- PHASE2
NUCALA® Special Drug Use Investigation (EGPA, Long-term)
- Status
- COMPLETED
- Phase
- N/A